These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11141397)

  • 21. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive multifocal leukoencephalopathy.
    Cei M; Mumoli N; Ferrito G; Scazzeri F
    South Med J; 2010 Oct; 103(10):1074-5. PubMed ID: 20818319
    [No Abstract]   [Full Text] [Related]  

  • 23. Listerial brain abscess in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Cleveland KO; Gelfand MS
    Clin Infect Dis; 1993 Oct; 17(4):816-7. PubMed ID: 8268374
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    Field K; Slavin MA; Seymour JF
    Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive multifocal leukoencephalopathy--a case report and review of the literature.
    Smolle E; Trojan A; Schuster SJ; Haybaeck J
    In Vivo; 2014; 28(5):941-8. PubMed ID: 25189911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytopenia and fludarabine.
    Jaccard A; Oksenhendler E; Clauvel JP
    Lancet; 1993 Oct; 342(8878):1049-50. PubMed ID: 8105278
    [No Abstract]   [Full Text] [Related]  

  • 29. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.
    Sanders C; Perez EA; Lawrence HJ
    Am J Hematol; 1992 Apr; 39(4):314-5. PubMed ID: 1553963
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone.
    D'Arena G; Gasperini C; Cascavilla N
    Tumori; 2009; 95(3):406-7. PubMed ID: 19688989
    [No Abstract]   [Full Text] [Related]  

  • 31. Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
    Tisler A; Pierratos A; Lipton JH
    Nephrol Dial Transplant; 1996 Nov; 11(11):2306-8. PubMed ID: 8941597
    [No Abstract]   [Full Text] [Related]  

  • 32. Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
    Benetatos L; Hatzimichael E; Vassou A; Bourantas KL
    Leuk Res; 2007 Jan; 31(1):119-20. PubMed ID: 16620969
    [No Abstract]   [Full Text] [Related]  

  • 33. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine].
    Díaz-Pedroche C; Lizasoain M; Folgueira D; Giménez-Mesa E; Aguado JM
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):61-3. PubMed ID: 16537066
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
    [No Abstract]   [Full Text] [Related]  

  • 38. A "progressive" visual loss.
    Capaldi L; Ursella S; Miele L; Larussa D; Pallavicini F; Gasbarrini G; Grieco A; Gentiloni Silveri N
    Ann Ital Med Int; 2004; 19(2):118-21. PubMed ID: 15317272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 40. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.
    Pejsa V; Lucijanic M; Jonjic Z; Prka Z; Vukorepa G
    Ann Hematol; 2019 Jun; 98(6):1509-1510. PubMed ID: 30421169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.